Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000011033 | SCV001473198 | pathogenic | Hereditary factor VIII deficiency disease | 2021-05-18 | criteria provided, single submitter | clinical testing | The F8 c.6545G>A; p.Arg2182His variant (rs137852466), also known as p.Arg2163His, is reported in the literature in multiple individuals affected with moderate to severe hemophilia A (see link to Factor VIII database and references therein; Jayandharan 2017, Johnsen 2017, Tuddenham 1994). This variant is reported in ClinVar (Variation ID: 10320), and is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The arginine at codon 2182 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Additionally, other variants at this codon (c.6544C>T; p.Arg2182Cys, c. 6544C>G; p.Arg2182Gly) have been reported in individuals with severe hemophilia A and are considered pathogenic (see link to Factor VIII database, Jayandharan 2009). Based on available information, this variant is considered to be pathogenic. References: Link to Factor VIII database: http://www.factorviii-db.org Jayandharan GR et al. Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia. 2009 Nov;15(6):1228-36. Johnsen JM et al. Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative. Blood Adv. 2017 May 18;1(13):824-834. Tuddenham EG et al. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition. Nucleic Acids Res. 1994 Nov 11;22(22):4851-68. |
Genetics and Molecular Pathology, |
RCV000011033 | SCV002761416 | pathogenic | Hereditary factor VIII deficiency disease | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000011033 | SCV005204121 | pathogenic | Hereditary factor VIII deficiency disease | 2024-06-21 | criteria provided, single submitter | clinical testing | Variant summary: F8 c.6545G>A (p.Arg2182His) results in a non-conservative amino acid change located in the coagulation factor 5/8 C-terminal domain (IPR000421) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183342 control chromosomes. c.6545G>A has been reported in the literature in multiple individuals affected with Factor VIII Deficiency (Hemophilia A) (e.g.Miller_2012, Eckhardt_2013, Azadmehr_2021) . These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 35014236, 23926300, 22103590). ClinVar contains an entry for this variant (Variation ID: 10320). Based on the evidence outlined above, the variant was classified as pathogenic. |
Gene |
RCV004821959 | SCV005442886 | pathogenic | not provided | 2024-07-02 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as Arg2163His; This variant is associated with the following publications: (PMID: 35014236, 7937051, 7984443, 29490426, 32190902, 36595620, 33245802, 33706050, 24845853, 10215414, 36983317, 9829908, 38196513, 34844950, 32224444, 19473423, 34272389, 34788507, 34708896, 32897612, 9569189, 10404764, 11341489, 11554935, 15710596, 15810915, 16086318) |
OMIM | RCV000011033 | SCV000031260 | pathogenic | Hereditary factor VIII deficiency disease | 1995-01-01 | no assertion criteria provided | literature only | |
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, |
RCV000011033 | SCV001424863 | pathogenic | Hereditary factor VIII deficiency disease | 2019-06-01 | no assertion criteria provided | clinical testing |